Abstract
Introduction
Inflammation is considered to play an important role in the pathogenesis of atherosclerosis [1] . Leukocyte count is a simple, inexpensive and well-standardized biomarker of acute or chronic inflammation [2] . Some epidemiologic studies [2] [3] [4] [5] have demonstrated that high leukocyte count is an independent risk factor for future coronary heart disease (CHD). Only few prospective studies [6] [7] examined the association between leukocyte count and incidence of stroke.
In most prospective studies [4] [5] [6] [7] , the effects of various risk factors are evaluated over a few years follow-up after the baseline examination. Studies of the long-term withinperson variation of inflammatory markers have shown that e.g., C-reactive protein (CRP), erythrocyte sedimentation rate and white blood cells are quite stable over time [8, 9] , and many markers of inflammation, including the leukocyte concentrations, are strongly influenced by genetic factors [10] . This suggests that inflammatory markers could be useful in long-term prediction of cardiovascular disease (CVD). However, studies of CRP have reported that the increased risk associated with high concentrations decline after a few year of follow-up, particularly in the elderly [11, 12] . It is unclear whether the impact of raised leukocyte concentrations on the risk of CVD remains over a very long follow-up period.
The purpose of this population-based study is to examine whether leukocyte count is associated with incidence of coronary events (CE) or stroke in a long-term prospective investigation among Swedish middle-aged men and women.
Methods

Study population
The main purpose of the Malmö Preventive Project (MPP) was to identify high-risk individuals for CVD in an urban-population, Malmö, Sweden. The MPP has been described in detail previously [13] . In short, complete birth cohorts, born between 1921 and 1949, were invited. A total of 22,444 men were examined between 1974 and 1984, and 10,902 women were examined between 1977 and 1992. Participation rate was approximately 71% [13] . The health examination included a physical examination, a panel of laboratory tests and self-administered questionnaire with items relevant for the occurrence of CVD [13] .
Leukocyte count was analyzed in participants during the period of 1975-1980 (i.e. in 17,223 men and 2,937 women). In the present study, subjects with a history of myocardial infarction (MI) or stroke (according to questionnaire and/or hospital records, n=72), or with missing value of body mass index (BMI) or blood pressure (BP) (n=17), or with extremely high leukocyte values (i.e.>20.0 x10 9 cells/L, n=8) were excluded from the analysis. Thus, the total study population consisted of 17,131 men (mean age: 44±5 years, range: 27-61) and 2,932 women (mean age: 42±9 years, range: 28-56).
The health service authority of Malmö approved and funded the screening program. All participants gave informed consent.
Baseline characteristics
Information on baseline characteristics, which has been presented previously [9] , was collected from self-administered questionnaire and clinical examination. Smoking habits were categorized into never, former (i.e. smokers who had quit smoking at least 1 year before the examination), and current smokers (i.e. daily smoking with <20 and ≥20 cigarettes/day, respectively) [14] . High alcohol consumption was assessed by means of the modified and shortened version of the Michigan Alcoholism Screening Test [15] .
Subjects with more than two (of nine) affirmative answers were considered to have high alcohol consumption. Two categories were used for the classification of leisure-time physical activity, e.g. sedentary or not. Diabetes mellitus was defined as fasting whole blood glucose > 6.1mmol/L and/or self-reported diabetes according to the questionnaire.
Information on current use of BP-lowering medication was also included in the questionnaire.
By using mercury sphygmomanometer, BP (mmHg) was measured twice in the right arm after a 10-minutes rest. The average of two measurements was used. Hypertension was defined as systolic BP ≥140 mmHg and/or diastolic BP ≥ 90 mmHg or use of BPlowering medication [16] . BMI was calculated as weight/height 2 (kg/m 2 ) and further categorized into normal weight (BMI<25.0) and overweight/obese (BMI≥25.0) subgroups.
Laboratory tests
Blood samples were taken after an overnight fast. Leukocyte counts (x10 9 cells/L) were analysed by using automatic counters in accordance with the standard methods at the laboratory of the Malmö university hospital. In the present analysis, the values of leukocyte count were categorized into sex-specific quartiles.
Serum cholesterol and triglycerides were similarly analysed with standard methods at the laboratory. Hyperlipidemia was defined as total cholesterol ≥5.0 mmol/L (i.e. ≥190 mg/dL) and/or triglyceride >1.7 mmol/L (i.e. >150 mg/dL) [17] .
Plasma fibrinogen was available in a subset of 6,018 men (aged 47±4 years) [14, 18] .
Electroimmuno assay was used to assess the plasma levels of fibrinogen [19] . The analysis was performed consecutively at the time of study entry.
Retrieval of endpoints
All subjects were followed from the baseline examination until first hospitalization due to incident MI, stroke or death, or December 31 st , 2004, whichever came first. The mean follow-up period was 24±6 years for men and 24±5 years for women. An acute coronary event (CE) was defined as fatal or non-fatal MI (ICD-9 codes: 410A-410X; ICD-10: I21) or death from chronic ischemic heart disease (ICD-9 codes: 410-414; ICD-10: I20-I25).
The records of patients with CE were retrieved by data linkage with the National Hospital Discharge Register and National Cause of Death Registry [20] . stroke as most of non-specified cases assumingly were caused by cerebral ischemia.
In subjects with more than one CE or stroke event, only the first event was used for the analysis.
Statistics
One-way analysis of variance and Chi-square test were used to examine baseline characteristics in relation to leukocyte quartiles. P values for the trend analyses were assessed by using general linear or logistic regression model with age-adjustment.
Power calculations were made for CE or stroke in men and women. Assuming a hazard ratio (HR) of 1.3, the statistical power for CE or stroke in men would be 99% and 95%, respectively, and 28% and 21% in women, respectively.
All analyses performed were sex-specific. Kaplan-Meier method was used to assess the rates of endpoints-free survival corresponding to the quartiles of leukocytes. Cox proportional hazards regression was used to compare incidences of endpoints in relation to leukocyte count (in quartiles), and to calculate risk factor adjusted HR (95% confidence interval, CI). The initial model was adjusted for age only. The fully adjusted model included potential confounders, i.e. the baseline characteristics which showed difference (i.e. p<0.10) between leukocyte counts in quartiles.
To explore the long-term ability of leukocyte levels to predict CVD risk, the analyses were also performed separately for events that occurred during the first 10 years of follow-up, and events that occurred after more than 10 years of follow-up. Furthermore, in men the assessments were performed stratified by the median age (i.e. 46 years) to determine whether the association was related to age. No similar analyses were performed in women due to limited number of events.
In men interactions between leukocyte concentrations and other risk factors (i.e. in terms of age groups, smoking habits, high alcohol intake, physical inactivity, overweight, hypertension, hyperlipidemia and diabetes) were explored by interaction terms in the covariate-adjusted regression models.
All comparisons were two-sided and a 5% level of significance was used. The statistical analyses were conducted by the computer software SPSS TM (version 14.5).
Results
Baseline characteristics
The mean values of leukocyte count at baseline examination were 6.1±2.0 x10 9 cells/L (inter-quartile range 4.6-7.1, range 2.0-19.2) in men, and 6.0±2.0 x10 9 cells/L (interquartile range 4.6-7.0, range 2.0-18.4) in women.
Baseline characteristics by quartiles of leukocytes are described in online Table 1 . High leukocyte counts were associated with current smoking, high alcohol intake, presence of diabetes and hyperlipidemia, higher levels of BMI, total cholesterol and triglycerides in both men and women. For systolic BP and physical inactivity, the positive significant association was only observed in men. 
Incidence of CE
Long-term relationship with incidence of CE
In all men, the difference in CE-free survival rate between the quartiles of leukocytes increased continuously over three decades of follow-up period (Figure 1 ). To further explore the risk of CE over time, the analyses were repeated for events that occurred within 10 years and after 10 years of follow-up, respectively ( 
Leukocyte count and CVD risk factors
Among men, the association between leukocytes and CE was examined in categories of other risk factors (Table 3 ). The impact of leukocytes on CE seemed to be most pronounced in men aged 27-46 years, in former or current smokers and in men without hypertension. Interaction analyses were also performed in men. Significant interactions on incidence of CE were observed between leukocyte count (as quartiles or as a continuous variable) and age (p<0.001) or hypertension (p<0.001).
Incidence of stroke
A total of 1,226 men and 107 women developed a first-ever stroke during follow-up. Of them, 1,098 (82.3%) were classified as ischemic infarction, 162 (12.2%) as cerebral hemorrhage and 73 (5.5%) as subarachnoid hemorrhage (Table 4) . In this study, only total stroke and ischemic subtype was examined.
In men, a significant difference in leukocyte count was observed between stroke cases and non-cases (6.3±2.0 vs.6.0±2.0 x10 9 cells/L, p<0.001). No significant difference was found in women (6.3±2.4 vs.6.0±2.0 x10 9 cells/L, p=0.10). The age-adjusted HR increased moderately across the quartiles of leukocytes in both men and women (Table 4) .
However, the trends became non-significant in both sexes after adjustments for potential confounders. The results were similar when ischemic stroke was analyzed.
Discussion
Over an average of 24 years follow-up, raised leukocyte concentrations were associated with increased incidence of CE in men. The increased risk was moderate but persistent, in a dose-response manner, independently of other cardiovascular risk factors and fibrinogen. The association was stable over more than ten years of follow-up in younger, but not in older men. Leukocyte count had no notable association with incidence of stroke.
It is still questioned whether leukocytes are involved in the pathogenesis of CVD or are only a risk marker for other risk factors causing the disease. It has been reported that leukocytes participate in the formation of atheromas, even in the earliest stage of the disease process [22] . It is also suggested that leukocytes may affect the cardiovascular system through other pathologic mechanisms, such as mediating inflammation, causing proteolytic and oxidative damage to the endothelial cells, plug the microvasculature, inducing hyper-coagulability, and promotion of infarct expansion [5] . Results from this and other epidemiological studies [4, 5] also indicate that elevated leukocyte count is a risk factor for coronary events, even after adjustments for many established CVD risk factors.
In contrast to incidence of CE, there were no significant relationship between leukocyte count and incidence of stroke in this study. Even though the pathogenesis of CHD and ischemic stroke show many similarities, both CE and ischemic stroke are heterogeneous disorders and there are well-known differences in their relationship with CVD risk factors [23] . For example, cholesterol and male sex seem to be more linked to CHD, while age and blood pressure seem to be more important for the risk of stroke. Different relationships between leukocytes and incidence of CE and stroke were also reported by Gillum et al [24] . The reason for the differential relationships is not obvious. The statistical power in this study was high, both for the analysis of CE and stroke in men.
The results suggest that leukocyte concentration may be another risk factor which is more important for incidence of CE than for stroke in men.
In studies of elderly, it has been reported that inflammatory markers show a time-to-event dependency [11, 12] , and that the prognostic value of inflammatory markers on CVD attenuate after a few years of follow-up. In the present study, the leukocyte count was associated with CE even after more than ten years of follow-up. However, this was true only for younger men (aged 27-46 years), and not for the older age group (aged 47-61 years). In our sub-group analyses, the impact of leukocyte count on risk of CE was stronger among men who had lower risk of CVD, i.e. younger men or men who were normotensive. A similar relationship was reported by another study, in which elevated leukocyte count was associated with increased risk of CVD mainly in women without established CVD risk factors [4] . Since the occurrence of atherosclerosis generally is lower in these groups, this suggests that high leukocyte concentrations in plasma may reflect early phases of atherogenesis. It has been suggested that, in younger individuals, inflammatory biomarkers reflect the progression toward vascular lesions and therefore yield both short-and long-term prediction, while in older people inflammatory markers may reflect the degree of complex advanced vascular disease burden, as well as other morbidities, with the highest levels reflecting severe pathology associated with early risk [11] . Our results are in accordance with that hypothesis.
Few studies [4, 25] have assessed the relationship between leukocyte count and incidence of CVD in women. In the Women's Health Initiative Observational Study [4] , women in the fourth quartile of leukocytes had over a 2-fold increased risk for CHD death and more than 40% increased risk for non-fatal CHD and stroke. Similar results have been reported from a large prospective study [25] . In our study, the point estimates were largely similar for men and women. It is likely that the absence of significant relationships among women in the present study could be explained by low statistical power.
The strength of this study lies in the large, prospective and population-based study design with a very long follow up period. Because of the long follow up, a large number of events were recorded, allowing outcome analysis of both the first decade and the complete follow-up period. In addition, information on several potential confounders was also available. Some limitations of this study are worth noting. Lack of repeated measurements of leukocyte count is a limitation, which may result in underestimation of the true association. As to the intra-individual variability of leukocytes, it was shown that the leukocyte count is fairly stable over time [9] . Lack of information on leukocyte differentials is also a limitation. The high risk of CVD associated with total leukocytes has been mainly accounted for by increased granulocyte count [25] . Furthermore, some individuals in the top quartile of leukocytes maybe had an infection, which caused raised leukocyte concentrations at the time of screening. Another weakness is lacking information on sub fractions of blood lipids, i.e. HDL-and LDL-cholesterol, in the present study.
Conclusion
In this long-term prospective population-based study, elevated leukocyte count was associated with incidence of CE in men. The risks were moderate but independent of multiple cardiovascular risk factors. The increased risk persisted after more than ten years of follow-up in younger men, but not in older age groups. However, there was no significant association between leukocyte count and incidence of stroke.
Online Table 1 . Baseline characteristics in relation to sex-specific quartiles of leukocyte counts. HR, hazards rate; CI, confidence interval; BP, blood pressure; BMI, body mass index. † HRs were adjusted for age, smoking habits, high alcohol intake, physical inactivity, BMI, systolic BP, BP-lowering medication, presence of diabetes, total cholesterol and log transformed triglycerides (when appropriate). ‡ The definitions of risk categories were described in Methods section. 
